Researchers use CRISPR gene editing technology to target GABA receptors in order to help treat mood disorders.
Patients reported a greater reduction of depressive symptoms when taking saffron extract in addition to antidepressants.
Researchers have discovered a serotonin type 3 receptor activator that produces an antidepressant effect in mice and functions independently of SSRIs.
Researchers reveal a link between serotonin and patience at the prospect of reward in mice.
A synthetic compound, decynium-22, is able to turn off SERT in the brain, enhancing the effectiveness of SSRIs.
A new study reports cognitive therapy appears to be most effective for treating social anxiety disorder.
Antidepressants for major depressive disorder reduce the aversive response triggered by exposure to the suffering of others. Findings suggest antidepressants may lead to impaired empathy of pain perception.
A new Nature Communications study reports the antidepressant Clomipramine may relieve symptoms of primary progressive multiple sclerosis.
Researchers report the antidepressant paroxetine suppresses neuroinflammation in improves reaction time in people with HIV associated cognitive impairment.
According to a new study, pregnant women who take SSRI antidepressants have lower risks of certain pregnancy complications. However, there is an increased risk of neonatal problems associated with mothers who take the medications.
Researchers identify a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy. The experimental results explain how these therapies likely work to relieve depression by stimulating stem cells in the brain to grow and mature.
A new study reports prenatal exposure to common antidepressants and antipsychotics does not increase the risk of a child developing autism.
